Trial Profile
A Multi-Center, Open-Label, Surgical Surveillance Trial To Evaluate The Safety And Efficacy Of A Shortened Infusion Time of Intravenous Ibuprofen
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jan 2019
Price :
$35
*
At a glance
- Drugs Ibuprofen (Primary)
- Indications Postoperative pain
- Focus Adverse reactions
- Sponsors Cumberland Pharmaceuticals
- 12 Jan 2015 Results published in Clinical Therapeutics.
- 19 Feb 2013 Top-line results have been reported in a Cumberland Pharmaceuticals media release.
- 19 Feb 2013 Status changed from recruiting to completed based on information reported in a Cumberland Pharmaceuticals media release.